SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Synta Pharmaceuticals
SNTA 0.343+26.6%Jul 22 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: kenhott2/2/2009 8:47:08 AM
   of 112
 
Synta Seeing Unusual Options Activity

02/02/09 - 07:34 AM EST
Synta Pharmaceuticals Corporation| SNTA

Biopharmaceutical company Synta(SNTA Quote - Cramer on SNTA - Stock Picks) is seeing some unusual options activity a week before presenting at a major industry conference.

OptionMonster's tracking systems picked up a large trade Friday that included the purchase of 3,131 May 12.50 calls and the sale of 3,073 May 7.50 puts for $3.60. The stock has been steadily rising, especially in the last few weeks, and popped 6.28% Friday to $8.80, roughly double its lows of December.

Pharmaceutical stocks have been particularly active recently as the industry undergoes consolidation, and Synta already has a strategic relationship with Swiss drug giant Roche. With a $288 million market cap, Synta could be gobbled up in a single bite.

Another potential catalyst for the stock could be the BIO CEO & Investor conference next week in New York. Synta is scheduled to present at the conference on Feb. 9.

---------------------
I see they have picked up on your trades. :)
---------------------
Enrollment completed. Data by May 09.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext